News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
838,222 Results
Type
Article (86069)
Company Profile (649)
Press Release (751504)
Multimedia
Podcasts (126)
Webinars (13)
Section
Business (232203)
Career Advice (4124)
Deals (39706)
Drug Delivery (126)
Drug Development (90790)
Employer Resources (198)
FDA (17995)
Job Trends (17320)
News (395530)
Policy (39667)
Tag
2024 BioCapital Digital (20)
2024 BioForest Digital (16)
2024 BioForest Standard (1)
2024 BioMidwest Digital (14)
2024 BioMidwest Standard (2)
2024 Bio NC Digital (19)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (20)
2024 Biotech Beach Digital (15)
2024 Biotech Beach Standard (9)
2024 Genetown Digital (10)
2024 Genetown Standard (11)
2024 Lone Star Bio Digital (17)
2024 Pharm Country Digital (13)
2024 Pharm Country Standard (6)
2025 BioForest Digital (7)
2025 Lone Star Bio Digital (8)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Bio NC Standard (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Genetown Standard (1)
2026 Pharm Country Elite (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (2)
Academia (2991)
Academic (1)
Accelerated approval (6)
Adcomms (25)
Allergies (78)
Alliances (56648)
ALS (78)
Alzheimer's disease (1465)
Antibody-drug conjugate (ADC) (131)
Approvals (17980)
Artificial intelligence (218)
Autoimmune disease (26)
Automation (11)
Bankruptcy (402)
Best Places to Work (12511)
BIOSECURE Act (22)
Biosimilars (118)
Biotechnology (447)
Bladder cancer (64)
Brain cancer (25)
Breast cancer (223)
Cancer (1907)
Cardiovascular disease (138)
Career advice (3529)
Career pathing (33)
CAR-T (155)
Cell therapy (434)
Cervical cancer (17)
Clinical research (72737)
Collaboration (754)
Compensation (436)
Complete response letters (28)
COVID-19 (2826)
CRISPR (42)
C-suite (212)
Cystic fibrosis (99)
Data (1767)
Decentralized trials (2)
Denatured (44)
Depression (37)
Diabetes (182)
Diagnostics (6746)
Digital health (9)
Diversity (9)
Diversity, equity & inclusion (48)
Drug discovery (115)
Drug pricing (92)
Drug shortages (17)
Duchenne muscular dystrophy (80)
Earnings (95216)
Editorial (36)
Employer branding (25)
Employer resources (167)
Events (128197)
Executive appointments (604)
FDA (18912)
Featured Employer (63)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (628)
Gene editing (97)
Generative AI (22)
Gene therapy (307)
GLP-1 (732)
Government (5104)
Grass and pollen (4)
Guidances (35)
Healthcare (20743)
Huntington's disease (25)
IgA nephropathy (26)
Immunology and inflammation (124)
Indications (23)
Infectious disease (2940)
Inflammatory bowel disease (147)
Inflation Reduction Act (11)
Influenza (42)
Intellectual property (82)
Interviews (812)
IPO (17684)
IRA (38)
Job creations (5184)
Job search strategy (2861)
Kidney cancer (10)
Labor market (39)
Layoffs (536)
Leadership (20)
Legal (10056)
Liver cancer (70)
Lung cancer (278)
Lymphoma (127)
Machine learning (4)
Management (65)
Manufacturing (276)
MASH (65)
Medical device (14294)
Medtech (14299)
Mergers & acquisitions (22269)
Metabolic disorders (582)
Multiple sclerosis (73)
NASH (22)
Neurodegenerative disease (96)
Neuropsychiatric disorders (23)
Neuroscience (1943)
NextGen: Class of 2025 (7666)
Non-profit (5054)
Northern California (2238)
Now hiring (39)
Obesity (314)
Opinion (270)
Ovarian cancer (68)
Pain (64)
Pancreatic cancer (60)
Parkinson's disease (131)
Partnered (19)
Patents (190)
Patient recruitment (88)
Peanut (48)
People (64850)
Pharmaceutical (131)
Pharmacy benefit managers (13)
Phase I (22469)
Phase II (31620)
Phase III (23783)
Pipeline (977)
Policy (136)
Postmarket research (3542)
Preclinical (10094)
Press Release (72)
Prostate cancer (82)
Psychedelics (34)
Radiopharmaceuticals (249)
Rare diseases (353)
Real estate (7383)
Recruiting (75)
Regulatory (26390)
Reports (55)
Research institute (2646)
Resumes & cover letters (649)
Rett syndrome (1)
RNA editing (4)
RSV (34)
Schizophrenia (67)
Series A (122)
Series B (70)
Service/supplier (25)
Sickle cell disease (46)
Southern California (1917)
Special edition (18)
Spinal muscular atrophy (164)
Sponsored (33)
Startups (4282)
State (2)
Stomach cancer (11)
Supply chain (50)
Tariffs (28)
The Weekly (80)
United States (19331)
Vaccines (722)
Venture capitalists (38)
Weight loss (227)
Women's health (36)
Worklife (19)
Date
Today (90)
Last 7 days (379)
Last 30 days (1986)
Last 365 days (29266)
2025 (7866)
2024 (34034)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1265)
Alabama (53)
Alaska (6)
Arizona (243)
Arkansas (8)
Asia (49792)
Australia (8792)
California (5108)
Canada (1541)
China (473)
Colorado (162)
Connecticut (207)
Delaware (122)
Europe (113944)
Florida (637)
Georgia (145)
Hawaii (1)
Idaho (64)
Illinois (434)
India (25)
Indiana (267)
Iowa (9)
Japan (127)
Kansas (109)
Kentucky (16)
Louisiana (8)
Maine (58)
Maryland (824)
Massachusetts (4048)
Michigan (182)
Minnesota (306)
Mississippi (1)
Missouri (53)
Montana (24)
Nebraska (26)
Nevada (52)
New Hampshire (50)
New Jersey (1480)
New Mexico (27)
New York (1455)
North Carolina (985)
North Dakota (7)
Northern California (2238)
Ohio (159)
Oklahoma (13)
Oregon (44)
Pennsylvania (1083)
Puerto Rico (11)
Rhode Island (23)
South America (1648)
South Carolina (4)
South Dakota (1)
Southern California (1917)
Tennessee (30)
Texas (680)
Utah (112)
Virginia (98)
Washington D.C. (38)
Washington State (504)
West Virginia (1)
Wisconsin (38)
838,222 Results for "tela bio".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
TELA Bio to Announce First Quarter 2025 Financial Results
April 17, 2025
·
2 min read
Press Releases
TELA Bio Reports Fourth Quarter and Full Year 2024 Financial Results
March 20, 2025
·
10 min read
Press Releases
TELA Bio Announces U.S. Commercial Launch of Larger Sizes of OviTex® PRS for Plastic and Reconstructive Surgery
April 1, 2025
·
5 min read
Press Releases
TELA Bio to Announce Fourth Quarter and Full Year 2024 Financial Results
February 28, 2025
·
2 min read
Press Releases
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - February 21, 2025
February 24, 2025
·
2 min read
Press Releases
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
January 24, 2025
·
2 min read
Business
TELA Bio Appoints Greg Firestone as Chief Commercial Officer
TELA Bio, Inc., a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, announced the appointment of Greg Firestone as the Company’s new Chief Commercial Officer.
May 20, 2024
·
5 min read
Business
TELA Bio Appoints Jeffrey Blizard to its Board of Directors
TELA Bio, Inc. announced that it has appointed Jeffrey Blizard, the Global Head of Surgical Sales for Abiomed, a medical device technology company that operates as a stand-alone business within Johnson & Johnson’s MedTech Segment, to its Board of Directors, effective June 4, 2024.
June 4, 2024
·
3 min read
Business
TELA Bio to Announce First Quarter 2024 Financial Results
TELA Bio, Inc. today announced that the Company will report first quarter 2024 financial results on Thursday, May 9, 2024.
April 25, 2024
·
2 min read
Business
TELA Bio Reports First Quarter 2024 Financial Results
TELA Bio, Inc., a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions reported financial results for the first quarter ended March 31, 2024.
May 9, 2024
·
8 min read
1 of 83,823
Next
